MedTrace Logo

A Novel Imaging Based Quantitative Model-aided Detection of Portal Hypertension in Patients With Cirrhosis (CHESS2104)

NCT05068492 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2023-04-25

No results posted yet for this study

Summary

How to construct a novel, non-invasive, accurate, and convenient method to achieve prediction of hepatic venous pressure gradient (HVPG) is an important general problem in the management of portal hypertension in cirrhosis. We plan to investigate the ability of AI analysis of Ultrasound, computed tomography (CT) or magnetic resonance (MR) to establish a risk stratification system and perform tailored management for portal hypertension in cirrhosis.

Conditions

  • Portal Hypertension

Interventions

DIAGNOSTIC_TEST

CT

enhanced CT with standard procedure

DIAGNOSTIC_TEST

MRI

enhanced MRI with standard procedure

DIAGNOSTIC_TEST

HVPG

HVPG measurements are performed by well-trained interventional radiologists in accordance with standard operating procedures

DIAGNOSTIC_TEST

Ultrasound

Digestive ultrasound with standard procedure

Sponsors & Collaborators

  • Portal Hypertension Alliance in China

    collaborator UNKNOWN

  • Hepatopancreatobiliary Surgery Institute of Gansu Province

    lead OTHER

Principal Investigators

  • Xiaolong Qi, Prof. · CHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, China

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-10
Primary Completion
2025-12-01
Completion
2025-12-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05068492 on ClinicalTrials.gov